X-linked partial corpus callosum agenesis with mild intellectual disability: identification of a novel L1CAM pathogenic variant.


Journal

Neurogenetics
ISSN: 1364-6753
Titre abrégé: Neurogenetics
Pays: United States
ID NLM: 9709714

Informations de publication

Date de publication:
03 2021
Historique:
received: 10 07 2020
accepted: 15 11 2020
pubmed: 9 1 2021
medline: 19 11 2021
entrez: 8 1 2021
Statut: ppublish

Résumé

Pathogenic variants in L1CAM, the gene encoding the L1 cell adhesion molecule, are responsible for a wide clinical spectrum including X-linked hydrocephalus with stenosis of the Sylvius aqueduct, MASA syndrome (mental retardation, aphasia, shuffling gait, adducted thumbs), and a form of spastic paraplegia (SPG1). A moderate phenotype with mild intellectual disability (ID) and X-linked partial corpus callosum agenesis (CCA) has only been related to L1CAM in one family. We report here a second family, including 5 patients with mild to moderate ID and partial CCA without signs usually associated with L1CAM pathogenic variations (such as hydrocephalus, pyramidal syndrome, thumb adductus, aphasia). We identified a previously unreported c.3226A > C transversion leading to a p.Thr1076Pro amino acid substitution in the fifth fibronectin type III domain (FnIII) of the protein which co-segregates with the phenotype within the family. We performed in vitro assays to assess the pathogenic status of this variation. First, the expression of the novel p.Thr1076Pro mutant in COS7 cells resulted in endoplasmic reticulum (ER) retention and reduced L1CAM cell surface expression, which is expected to affect both L1CAM-mediated cell-cell adhesion and neurite growth. Second, immunoblotting techniques showed that the immature form of the L1CAM protein was increased, indicating that this variation led to a lack of maturation of the protein. ID associated with CCA is not a common clinical presentation of L1CAM pathogenic variants. Genome-wide analyses will identify such variations and it is important to acknowledge this atypical phenotype.

Identifiants

pubmed: 33415589
doi: 10.1007/s10048-020-00629-y
pii: 10.1007/s10048-020-00629-y
doi:

Substances chimiques

L1CAM protein, human 0
Neural Cell Adhesion Molecule L1 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-51

Références

Brown WS, Jeeves MA, Dietrich R, Burnison DS (1999) Bilateral field advantage and evoked potential interhemispheric transmission in commissurotomy and callosal agenesis. Neuropsychologia 37(10):1165–1180
doi: 10.1016/S0028-3932(99)00011-1
Paul LK, Van Lancker-Sidtis D, Schieffer B, Dietrich R, Brown WS (2003) Communicative deficits in agenesis of the corpus callosum: nonliteral language and affective prosody. Brain Lang 85(2):313–324
doi: 10.1016/S0093-934X(03)00062-2
des Portes V, Rolland A, Velazquez-Dominguez J, Peyric E, Cordier M-P, Gaucherand P et al (2018) Outcome of isolated agenesis of the corpus callosum: a population-based prospective study. Eur J Paediatr Neurol 22(1):82–92
doi: 10.1016/j.ejpn.2017.08.003
Marsh APL, Heron D, Edwards TJ, Quartier A, Galea C, Nava C, Rastetter A, Moutard ML, Anderson V, Bitoun P, Bunt J, Faudet A, Garel C, Gillies G, Gobius I, Guegan J, Heide S, Keren B, Lesne F, Lukic V, Mandelstam SA, McGillivray G, McIlroy A, Méneret A, Mignot C, Morcom LR, Odent S, Paolino A, Pope K, Riant F, Robinson GA, Spencer-Smith M, Srour M, Stephenson SEM, Tankard R, Trouillard O, Welniarz Q, Wood A, Brice A, Rouleau G, Attié-Bitach T, Delatycki MB, Mandel JL, Amor DJ, Roze E, Piton A, Bahlo M, Billette de Villemeur T, Sherr EH, Leventer RJ, Richards LJ, Lockhart PJ, Depienne C (2017) Mutations in DCC cause isolated agenesis of the corpus callosum with incomplete penetrance. Nat Genet 49(4):511–514
doi: 10.1038/ng.3794
Marsh APL, Edwards TJ, Galea C, Cooper HM, Engle EC, Jamuar SS, Méneret A, Moutard ML, Nava C, Rastetter A, Robinson G, Rouleau G, Roze E, Spencer-Smith M, Trouillard O, Billette de Villemeur T, Walsh CA, Yu TW, IRC5 Consortium, Heron D, Sherr EH, Richards LJ, Depienne C, Leventer RJ, Lockhart PJ (2018) DCC mutation update: congenital mirror movements, isolated agenesis of the corpus callosum, and developmental split brain syndrome. Hum Mutat 39(1):23–39
doi: 10.1002/humu.23361
Adle-Biassette H, Saugier-Veber P, Fallet-Bianco C, Delezoide A-L, Razavi F, Drouot N et al (2013) Neuropathological review of 138 cases genetically tested for X-linked hydrocephalus: evidence for closely related clinical entities of unknown molecular bases. Acta Neuropathol (Berl) 126(3):427–442
doi: 10.1007/s00401-013-1146-1
Vos YJ, de Walle HEK, Bos KK, Stegeman JA, Ten Berge AM, Bruining M et al (2010) Genotype-phenotype correlations in L1 syndrome: a guide for genetic counselling and mutation analysis. J Med Genet. mars 47(3):169–175
doi: 10.1136/jmg.2009.071688
Weller S, Gärtner J (2001) Genetic and clinical aspects of X-linked hydrocephalus (L1 disease): mutations in the L1CAM gene. Hum Mutat 18(1):1–12
doi: 10.1002/humu.1144
Djabali M, Mattei MG, Nguyen C, Roux D, Demengeot J, Denizot F, Moos M, Schachner M, Goridis C, Jordan BR (1990) The gene encoding L1, a neural adhesion molecule of the immunoglobulin family, is located on the X chromosome in mouse and man. Genomics 7(4):587–593
doi: 10.1016/0888-7543(90)90203-7
Moos M, Tacke R, Scherer H, Teplow D, Früh K, Schachner M (1988) Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin. Nature 334(6184):701–703
doi: 10.1038/334701a0
Williams EJ, Furness J, Walsh FS, Doherty P (1994) Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. Neuron 13(3):583–594
doi: 10.1016/0896-6273(94)90027-2
Schmid RS, Maness PF (2008) L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth. Curr Opin Neurobiol 18(3):245–250
doi: 10.1016/j.conb.2008.07.015
Barbin G, Aigrot MS, Charles P, Foucher A, Grumet M, Schachner M et al (2004) Axonal cell-adhesion molecule L1 in CNS myelination. Neuron Glia Biol 1(1):65–72
doi: 10.1017/S1740925X04000092
Wei CH, Ryu SE (2012) Homophilic interaction of the L1 family of cell adhesion molecules. Exp Mol Med. 44(7):413–423
doi: 10.3858/emm.2012.44.7.050
Vos YJ, Hofstra RMW (2010) An updated and upgraded L1CAM mutation database. Hum Mutat 31(1):E1102–E1109
doi: 10.1002/humu.21172
Basel-Vanagaite L, Straussberg R, Friez MJ, Inbar D, Korenreich L, Shohat M et al (2006) Expanding the phenotypic spectrum of L1CAM-associated disease. Clin Genet. mai 69(5):414–419
doi: 10.1111/j.1399-0004.2006.00607.x
Redin C, Le Gras S, Mhamdi O, Geoffroy V, Stoetzel C, Vincent M-C et al (2012) Targeted high-throughput sequencing for diagnosis of genetically heterogeneous diseases: efficient mutation detection in Bardet-Biedl and Alström syndromes. J Med Genet 49(8):502–512
doi: 10.1136/jmedgenet-2012-100875
Geoffroy V, Pizot C, Redin C, Piton A, Vasli N, Stoetzel C et al (2015) VaRank: a simple and powerful tool for ranking genetic variants. Peer J 3:e796
doi: 10.7717/peerj.796
Marx M, Diestel S, Bozon M, Keglowich L, Drouot N, Bouché E, Frebourg T, Minz M, Saugier-Veber P, Castellani V, Schäfer MKE (2012) Pathomechanistic characterization of two exonic L1CAM variants located in trans in an obligate carrier of X-linked hydrocephalus. Neurogenetics. févr 13(1):49–59
doi: 10.1007/s10048-011-0307-4
Rünker AE, Bartsch U, Nave K-A, Schachner M (2003) The C264Y Missense Mutation in the extracellular domain of L1 impairs protein trafficking in vitro and in vivo. J Neurosci 23(1):277–286
doi: 10.1523/JNEUROSCI.23-01-00277.2003
De Angelis E (2002) Disease-associated mutations in L1 CAM interfere with ligand interactions and cell-surface expression. Hum Mol Genet 11(1):1–12
doi: 10.1093/hmg/11.1.1
De Angelis E (1999) Pathological missense mutations of neural cell adhesion molecule L1 affect homophilic and heterophilic binding activities. Embo J 18(17):4744–4753
doi: 10.1093/emboj/18.17.4744
Bateman A, Jouet M, MacFarlane J, Du JS, Kenwrick S, Chothia C (1996) Outline structure of the human L1 cell adhesion molecule and the sites where mutations cause neurological disorders. Embo J 15(22):6050–6059
doi: 10.1002/j.1460-2075.1996.tb00993.x
Jouet M, Feldman E, Yates J, Donnai D, Paterson J, Siggers D, Kenwrick S (1993) Refining the genetic location of the gene for X linked hydrocephalus within Xq28. J Med Genet 30(3):214–217
doi: 10.1136/jmg.30.3.214
Jouet M, Moncla A, Paterson J, McKeown C, Fryer A, Carpenter N et al (1995) New domains of neural cell-adhesion molecule L1 implicated in X-linked hydrocephalus and MASA syndrome. Am J Hum Genet 56(6):1304–1314
pubmed: 7762552 pmcid: 1801103
Richards S, Aziz N, Bale S, Bick D, Das S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–423
doi: 10.1038/gim.2015.30
Gu SM, Orth U, Veske A, Enders H, Klunder K, Schlosser M et al (1996) Five novel mutations in the L1CAM gene in families with X linked hydrocephalus. J Med Genet 33(2):103–106
doi: 10.1136/jmg.33.2.103

Auteurs

Idriss Bousquet (I)

Department of Genetics and Reference Center for Developmental Disorders, Lyon University Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.

Muriel Bozon (M)

University of Lyon, University of Lyon 1 Claude Bernard Lyon 1, NeuroMyoGene Institute, CNRS UMR5310, INSERM U1217, Lyon, France.

Valérie Castellani (V)

University of Lyon, University of Lyon 1 Claude Bernard Lyon 1, NeuroMyoGene Institute, CNRS UMR5310, INSERM U1217, Lyon, France.

Renaud Touraine (R)

Genetics Department, Saint-Etienne University Hospital, Saint-Etienne, France.

Amélie Piton (A)

Department of Translational Medicine and Neurogenetics, Illkirch-Graffenstaden, France.
Molecular Genetic Unit, Strasbourg University Hospital, Strasbourg, France.

Bénédicte Gérard (B)

Molecular Genetic Unit, Strasbourg University Hospital, Strasbourg, France.

Laurent Guibaud (L)

Department of Pediatric and Fetal Imaging, Lyon University Hospital GHE, Bron, France.

Damien Sanlaville (D)

Department of Genetics and Reference Center for Developmental Disorders, Lyon University Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.
GENDEV Team, CRNL, INSERM U1028 CNRS UMR5292 UCBL1, Lyon, France.

Patrick Edery (P)

Department of Genetics and Reference Center for Developmental Disorders, Lyon University Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.
GENDEV Team, CRNL, INSERM U1028 CNRS UMR5292 UCBL1, Lyon, France.

Pascale Saugier-Veber (P)

Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, F 76000, Rouen, France.

Audrey Putoux (A)

Department of Genetics and Reference Center for Developmental Disorders, Lyon University Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France. audrey.putoux@chu-lyon.fr.
GENDEV Team, CRNL, INSERM U1028 CNRS UMR5292 UCBL1, Lyon, France. audrey.putoux@chu-lyon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH